Concentrix (NASDAQ:CNXC) Updates FY 2025 Earnings Guidance

Key Points

• Concentrix has updated its FY 2025 guidance, projecting earnings per share between 11.110-11.230, slightly above the consensus estimate of 11.150, with revenue guidance aligned at $9.8 billion.
• The company's stock is currently trading around $54.99, showing a decrease of $0.61 during midday trading, and has a market capitalization of $3.47 billion.
• Analysts have mixed views on Concentrix, with one analyst maintaining a "Strong Buy" rating while others have downgraded their ratings and target prices, resulting in a consensus rating of "Buy" with a price target of $69.50.

Concentrix (NASDAQ:CNXC - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 11.110-11.230 for the period, compared to the consensus earnings per share estimate of 11.150. The company issued revenue guidance of $9.8 billion-$9.8 billion, compared to the consensus revenue estimate of $9.8 billion. Concentrix also updated its Q4 2025 guidance to 2.850-2.960 EPS.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Wall Street Zen downgraded Concentrix from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st. Bank of America lowered their target price on Concentrix from $65.00 to $61.00 and set a "neutral" rating for the company in a research note on Friday, June 27th. Robert W. Baird raised their target price on Concentrix from $72.00 to $75.00 and gave the company an "outperform" rating in a research note on Thursday, September 18th. Canaccord Genuity Group restated a "buy" rating and set a $80.00 target price on shares of Concentrix in a research note on Tuesday. Finally, Barrington Research restated an "outperform" rating and set a $62.00 target price on shares of Concentrix in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Concentrix currently has a consensus rating of "Buy" and a consensus price target of $69.50.

Concentrix Stock Performance

CNXC stock traded down $0.61 during midday trading on Thursday, reaching $54.99. The company had a trading volume of 1,146,293 shares, compared to its average volume of 783,761. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.14. The stock has a 50 day moving average price of $52.74 and a 200 day moving average price of $52.56. Concentrix has a fifty-two week low of $36.28 and a fifty-two week high of $66.00. The firm has a market capitalization of $3.47 billion, a PE ratio of 15.11, a P/E/G ratio of 0.73 and a beta of 0.53.

Concentrix (NASDAQ:CNXC - Get Free Report) last issued its earnings results on Thursday, June 26th. The company reported $2.70 EPS for the quarter, missing analysts' consensus estimates of $2.76 by ($0.06). The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.38 billion. Concentrix had a net margin of 2.54% and a return on equity of 16.31%. The business's revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.69 earnings per share. Analysts anticipate that Concentrix will post 10.11 earnings per share for the current year.

Insider Buying and Selling at Concentrix

In related news, EVP Cormac J. Twomey sold 500 shares of the business's stock in a transaction that occurred on Wednesday, July 30th. The stock was sold at an average price of $57.91, for a total transaction of $28,955.00. Following the sale, the executive vice president owned 37,130 shares of the company's stock, valued at $2,150,198.30. The trade was a 1.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Geneos Wealth Management Inc. grew its holdings in shares of Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after acquiring an additional 522 shares in the last quarter. Osaic Holdings Inc. grew its holdings in shares of Concentrix by 13.4% during the 2nd quarter. Osaic Holdings Inc. now owns 2,222 shares of the company's stock valued at $118,000 after acquiring an additional 263 shares in the last quarter. Federated Hermes Inc. grew its holdings in shares of Concentrix by 81.6% during the 2nd quarter. Federated Hermes Inc. now owns 4,294 shares of the company's stock valued at $227,000 after acquiring an additional 1,930 shares in the last quarter. Creative Planning purchased a new position in shares of Concentrix during the 2nd quarter valued at $251,000. Finally, Corient Private Wealth LLC purchased a new position in shares of Concentrix during the 2nd quarter valued at $292,000. Institutional investors own 90.34% of the company's stock.

Concentrix Company Profile

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.